Ketamine therapy at IMH for depression
Singapore's Institute of Mental Health is using intravenous ketamine to treat patients with treatment-resistant depression. The therapy has shown success in improving mood and reducing suicidal thoughts where traditional antidepressants have failed.
Why it matters
It highlights a significant medical shift in treating severe depression using substances previously stigmatized as recreational drugs.
Ketamine, widely known as a party drug, has increasingly been harnessed as a treatment for depression.
The article provides a balanced medical overview of a clinical treatment, citing success rates and patient experiences.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in